OMGA
Omega Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website omegatherapeutics.com
- Employees(FY) 116
- ISIN US68217N1054
Performance
+29.03%
1W
+12.68%
1M
-29.41%
3M
-2.83%
6M
-20.27%
YTD
-60.4%
1Y
Profile
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Technical Analysis of OMGA 2024-05-31
Overview:
In analyzing the technical indicators for OMGA stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming trading ...
Recent News & Updates
- 2024-01-03 16:59
- 2024-01-02 03:05
- 2023-12-04 03:00
- 2023-11-27 06:01
- 2023-11-20 17:00
- 2023-11-20 03:00
- 2023-11-12 18:00
- 2023-11-08 18:00
- 2023-11-07 03:00
- 2023-10-31 22:30
- 2023-10-30 19:00
- 2023-10-18 22:30
- 2023-10-15 19:00
- 2023-10-11 04:00
- 2023-10-04 04:00
- 2023-10-01 19:00
- 2023-09-26 20:31
- 2023-09-25 19:00
- 2023-09-25 04:00
- 2023-09-21 04:00
- 2023-09-10 18:30
- 2023-08-28 19:00
- 2023-08-04 20:05
- 2023-08-03 05:15
- 2023-08-03 04:00
- 2023-07-19 19:39
Recursion (RXRX) Stock Surges 191% in 3 Months: Here's Why(Yahoo Finance)
- 2023-07-17 21:43
- 2023-07-11 19:00
- 2023-07-02 23:20
Baudax Bio (BXRX) Up 125% on Acquiring TeraImmune(Yahoo Finance)
- 2023-06-21 21:18